“The growth of the market is driven by factors such as increase in the usage and applications of sanger’s sequencing, especially in oncology research, diagnostics, reproductive health, and others. Furthermore, the market for sanger’s sequencing services has witnessed tremendous growth in the recent years, due to upsurge in demand for this technique in genomics, transcriptomics, and other life science-related research areas.”
The global sanger’s sequencing service market was valued at $192 million in 2013, and is projected to reach $1.08 billion by 2025, at a CAGR of 14.2% from 2018 to 2025. The report offers a detailed analysis of the key segments including top investment pockets, changing dynamics, market size & estimations, and competitive scenario.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/4611
The key drivers of the global sanger’s sequencing service market are surge in technological advancements, especially microfluidic sanger’s sequencing and rise in the number of collaborations & partnerships to promote the use of DNA sequencing in hospitals & research centers. In addition, heavy inflow of investment in R&D activities has facilitated the propagation of sanger’s sequencing services, thereby providing lucrative opportunities for the market players. However, concerns related to accuracy & standardization and dearth of skilled professionals hamper the market growth.
The United States was the leading revenue contributor to the global market in 2013, occupying nearly half of the total market share owing to high adoption rate of technologically advanced Sanger sequencing services. However, China is expected to grow at the highest CAGR of 17.2% from 2018 to 2025, owing to increase in disposable income; surge in research, development, & innovation activities; and growth in awareness of Sanger’s sequencing.
Key Findings of the Sanger’s Sequencing Service Market:
- EU accounted for more than one-third of the share of the sanger’s sequencing service market in 2013.
- The personalized medicine application segment is anticipated to grow with the highest CAGR throughout the forecast period.
- Academic and government research institutes accounted for nearly one-third of the global sanger’s sequencing service market in 2013.
- China is anticipated to grow at the highest rate in the market during the analysis period.
The key players analyzed in the report include:
Source BioScience, GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., LGC Science Group Limited, Fasteris SA, CeMIA SA, Quintara Biosciences, GenHunter Corporation, GENEWIZ, Nucleics, SciGenom Labs Pvt. Limited, and Microsynth AG. Inc.
The other players in the value chain (not included in the report) include
Laragen, Inc. and StarSEQ GmbH.
Scope of the Report
|Market size available for years||2013-2025|
|Base year considered||2014|
|Forecast units||Value (USD)|
|Segments covered||Application and End User|
|Geographies covered||North America, Europe, Asia-Pacific, LAMEA|
Next Generation Sequencing (NGS) Market by Product (Consumables, Platforms, and Services) Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, and Other Technologies), and End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, and Other End User): Global Opportunity Analysis and Industry Forecast, 2019–2026
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2048
DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 – 2025
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/163
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060